Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Tischer, Johanna  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Radujkovic, A., Dietrich, S., Blok, H.-J., Nagler, A., Ayuk, F., Finke, J., Tischer, J., Mayer, J., Koc, Y., Sorà, F., et al. (2019). Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.
Bazarbachi, A.Hamid, Hamed, R.Al, Labopin, M., Afanasyev, B., Hamladji, R.-M., Beelen, D., Eder, M., Scheid, C., Wu, D., Bunjes, D., et al. (2019). Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party.Bone Marrow Transplant.
I
Santoro, N., Labopin, M., Ciceri, F., van Lint, M.Teresa, Nasso, D., Blaise, D., Arcese, W., Tischer, J., Bruno, B., Ehninger, G., et al. (2019). Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age.Cancer.
Bazarbachi, A., Boumendil, A., Finel, H., Castagna, L., Dominietto, A., Blaise, D., Diez-Martin, J.L., Tischer, J., Gulbas, Z., Wallet, H.L., et al. (2019). Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.Br J Haematol.
K
Shimoni, A., Labopin, M., Lorentino, F., van Lint, M.Teresa, Koc, Y., Gulbas, Z., Tischer, J., Bruno, B., Blaise, D., Pioltelli, P., et al. (2018). Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.Leukemia.
O
Hubmann, M., Fritsch, S., Zoellner, A.-K., Prevalsek, D., Engel, N., Bücklein, V., Mumm, F., Schulz, C., Stemmler, H.Joachim, Jäger, G., et al. (2016). Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.J Clin Virol82, 33-40.
P
Vogt, V., Schick, J., Ansprenger, C., Braeu, M., Kroell, T., Kraemer, D., Köhne, C.-H., Hausmann, A., Buhmann, R., Tischer, J., et al. (2014). Profiles of Activation, Differentiation-Markers, or β-Integrins on T Cells Contribute to Predict T Cells' Antileukemic Responses After Stimulation With Leukemia-derived Dendritic Cells.J Immunother37, 331-347.
S
Christopeit, M., Kuss, O., Finke, J., Bacher, U., Beelen, D.Wilhelm, Bornhäuser, M., Schwerdtfeger, R., Bethge, W.Andreas, Basara, N., Gramatzki, M., et al. (2013). Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change.J Clin Oncol.
Fraccaroli, A., Prevalsek, D., Fritsch, S., Haebe, S., Bücklein, V., Schulz, C., Hubmann, M., Stemmler, H.-J., Ledderose, G., Hausmann, A., et al. (2018). Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS.Am J Hematol.
U
Ruggeri, A., Battipaglia, G., Labopin, M., Ehninger, G., Beelen, D., Tischer, J., Ganser, A., Schwerdtfeger, R., Glass, B., Finke, J., et al. (2016). Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study.J Hematol Oncol9, 89.